Learn more

FUNDAÇÃO OSWALDO CRUZ

Overview
  • Total Patents
    36
  • GoodIP Patent Rank
    113,824
  • Filing trend
    ⇩ 100.0%
About

FUNDAÇÃO OSWALDO CRUZ has a total of 36 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2002. It filed its patents most often in Brazil, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are FUNDACAO OSWALDO CRUZ, THE UNIV OF VERMONT AND STATE AGRICULTURE COLLEGE and CENIX BIOSCIENCE GMBH.

Patent filings per year

Chart showing FUNDAÇÃO OSWALDO CRUZs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Freire Marcos Da Silva 6
#2 Alves Ada Maria De Barcelos 5
#3 Galler Ricardo 5
#4 Azevedo Adriana De Souza 5
#5 Ferrara Maria Antonieta 4
#6 Siani Antonio Carlos 4
#7 Tappin Marcelo Raul Romero 4
#8 Bon Elba Pinto Da Silva 4
#9 Sampaio André Luiz Franco 4
#10 López Raquel Elisa Da Silva 4

Latest patents

Publication Filing date Title
WO2017156613A1 Modular apparatus and method for the analogous synchronisation of electroencephalograms with luminous events, oscillatory events of electrical nature, and motor behaviour events
BR102015025791A2 in vitro method to predict the toxicity of a test substance, use of adult human stem cells to predict the toxicity of a test substance, and diagnostic kit
AP201609462A0 Qualitative predictive method for differential diagnosis of pneumococcic, meningococcic and viral menigitis, differential meningitis diagnostic method and kit
BR102015000922A2 α-Ketoacylic compounds of isoniazid, process for obtaining said compounds and use of the compounds in the treatment of tuberculosis
BR102014030897A2 fungal extracts with p2x7 receptor antagonist activity, pharmaceutical composition containing said extracts, use of said extracts and extraction process
BR102014020443A2 compound, process for preparing a compound, pharmaceutical composition, use of a compound and method of treating cancer
BR102014019808A2 phenylaminopyrimidine-derived compounds, process for obtaining, use of said compounds in cancer treatment and treatment methods
EP2484376A1 Method, kit, plasmid and composition for inducing an immune response to dengue virus, on the basis of dna and chimeric virus vaccines
EP2324809A2 Alternative feeding device for infants at risk
EP3081231A2 Utilization of recombinant influenza viruses and modified vaccinia ankara virus (mva) with genes that encode for the toxoplasma gondii sag1 and sag2 surface proteins, as vaccines against toxoplasmosis
BRPI0604953A method and kit for quantitative identification of schistosoma mansoni nucleotide sequences
BRPI0604786A use of grandisin tetrahydrofuran lignan and use of a composition as an insecticide.
BR0305933A Chemical compositions for detection and control of triatomines
BR0204901A method for amplifying and identifying nucleotide sequences and kit for use in amplifying and identifying nucleotide sequences